Baltimore, Maryland, United States The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Baltimore.
The fund was created by Philip Goelet, Sydney Brenner MD PhD.
We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the various public portfolio startups of the fund, we may underline Corridor Pharmaceuticals, AgriMetis For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups.
The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2015.
The typical case for the fund is to invest in rounds with 5 participants. Despite the Acidophil, startups are often financed by Red Abbey Venture Partners, MedImmune Ventures, Syngenta Ventures. The meaningful sponsors for the fund in investment in the same round are Syngenta Ventures, Red Abbey Venture Partners, Quaker BioVentures. In the next rounds fund is usually obtained by Red Abbey Venture Partners, OUP (Osage University Partners), MedImmune Ventures.
Related Funds
| Fund Name | Location |
| Abalis Finance | Schwyz, Switzerland, Wollerau |
| Aizawa Securities | Japan, Tokyo |
| Cedar Street Group | Larchmont, New York, United States |
| Dexin Investment | China, Guangdong, Guangzhou |
| Fluxunit - Osram Ventures | Bayern, Germany, München |
| Ford Smart Mobility | California, Palo Alto, United States |
| HIT Robot Group | Beijing, Beijing, China |
| IKONIKA HOLDINGS PRIVATE LTD | Central, Central Region, Singapore |
| Marico | India, Maharashtra, Mumbai |
| Miller Value Partners | Baltimore, Maryland, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AgriMetis | $23M | 06 Jan 2017 | Maryland, United States | ||
AgriMetis | $7M | 13 Feb 2015 | Maryland, United States | ||
Corridor Pharmaceuticals | $13M | 24 Jun 2010 | Towson, Maryland, United States | ||
Corridor Pharmaceuticals | $2M | 23 Oct 2008 | Towson, Maryland, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AgriMetis | $23M | 06 Jan 2017 | Maryland, United States | ||
AgriMetis | $7M | 13 Feb 2015 | Maryland, United States | ||
Corridor Pharmaceuticals | $13M | 24 Jun 2010 | Towson, Maryland, United States | ||
Corridor Pharmaceuticals | $2M | 23 Oct 2008 | Towson, Maryland, United States |
